M. Rusckowski

发表

New indium-111 labeled biotin derivatives for improved immunotargeting.

F. Virzi, B. Fritz, M. Rusckowski, 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

In vivo hybridization of technetium-99m-labeled peptide nucleic acid (PNA).

M. Egholm, M. Rusckowski, D. Hnatowich, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Initial investigations of 99mTc-labeled morpholinos for radiopharmaceutical applications

M. Rusckowski, D. Hnatowich, Kennedy Mangera, 2001, European Journal of Nuclear Medicine.

Early results in the irrational design of new bifunctional chelators

M. Rusckowski, D. Hnatowich, F. Chang, 1997, Cancer.

Investigation of four (99m)Tc-labeled bacteriophages for infection-specific imaging.

M. Rusckowski, D. Hnatowich, Guozheng Liu, 2008, Nuclear medicine and biology.

JPET Miniseries : Imaging Assessing Antibody Pharmacokinetics in Mice with In Vivo Imaging

J. Hoppin, D. Cheng, M. Rusckowski, 2011 .

Improving the quantitation accuracy in noninvasive small animal single photon emission computed tomography imaging.

P. Pretorius, Xinrong Liu, Minmin Liang, 2011, Nuclear medicine and biology.

Pretargeting CWR22 prostate tumor in mice with MORF-B72.3 antibody and radiolabeled cMORF

P. Pretorius, Xinrong Liu, M. Rusckowski, 2008, European Journal of Nuclear Medicine and Molecular Imaging.

Pretargeting vs. direct targeting of human betalox5 islet cells subcutaneously implanted in mice using an anti-human islet cell antibody.

P. Streeter, D. Greiner, L. Shultz, 2012, Nuclear medicine and biology.

Human islet cell MORF/cMORF pretargeting in a xenogeneic murine transplant model.

P. Streeter, D. Greiner, L. Shultz, 2011, Molecular pharmaceutics.

Activin–like kinase–3 activity is important for kidney regeneration and reversal of fibrosis

V. LeBleu, R. Kalluri, M. Rusckowski, 2012, Nature Medicine.

Radiolabeled Zn-DPA as a potential infection imaging agent.

B. Gray, Xinrong Liu, Yuzhen Wang, 2012, Nuclear medicine and biology.

Pharmacokinetics of an indium-111-labeled monoclonal antibody in cancer patients.

R. L. Childs, P. Doherty, D. Shealy, 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Nonspecific cellular accumulation of 99mTc-labeled oligonucleotides in culture is influenced by their guanine content.

Xinrong Liu, M. Rusckowski, D. Hnatowich, 2007, Nuclear medicine and biology.

Auger-mediated cytotoxicity of cancer cells in culture by an 125I-antisense oligomer delivered as a three-component streptavidin nanoparticle.

Xinrong Liu, Minmin Liang, D. Cheng, 2010, Journal of biomedical nanotechnology.

Targeted scVEGF/177Lu radiopharmaceutical inhibits growth of metastases and can be effectively combined with chemotherapy

F. Blankenberg, M. Backer, J. Backer, 2016, EJNMMI Research.

Phenoxide-Bridged Zinc(II)-Bis(dipicolylamine) Probes for Molecular Imaging of Cell Death.

Bradley D. Smith, M. Suckow, Yuzhen Wang, 2016, Bioconjugate chemistry.

Synthesis and in vitro characterization of a dendrimer-MORF conjugate for amplification pretargeting.

Xinrong Liu, M. Rusckowski, D. Hnatowich, 2008, Bioconjugate chemistry.

Pretargeting of bacterial endocarditis in rats with streptavidin and 111In-labeled biotin.

P. Winnard, M. Rusckowski, D. Hnatowich, 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Keratinocyte-tethering modification for biologics enables location-precise treatment in mouse vitiligo

J. Richmond, M. Rusckowski, D. Siegel, 2022, bioRxiv.

Technetium-99m labeling of DNA oligonucleotides.

C. Cantor, C. Smith, P. Winnard, 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Amplification targeting: a modified pretargeting approach with potential for signal amplification-proof of a concept.

M. Rusckowski, D. Hnatowich, Guozheng Liu, 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Intraperitoneal therapy of ovarian cancer with Yttrium-90-labeled monoclonal antibodies : preliminary observations

P. Rose, T. Griffin, M. Rusckowski, 1991 .

Pretargeting with amplification using polymeric peptide nucleic acid.

S. Gupta, M. Rusckowski, D. Hnatowich, 2001, Bioconjugate chemistry.

Tumor pretargeting in mice using MORF conjugated CC49 antibody and radiolabeled complimentary cMORF effector.

P. Pretorius, G. Liu, M. Rusckowski, 2009, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

Radiolabeling morpholinos with 90Y, 111In, 188Re and 99mTc.

M. Rusckowski, D. Hnatowich, Yu-min Zhang, 2003, Nuclear medicine and biology.

Improving the labeling of S-acetyl NHS-MAG(3)-conjugated morpholino oligomers.

Zhihong Zhu, M. Rusckowski, D. Hnatowich, 2002, Bioconjugate chemistry.

Initial mechanistic studies of antisense targeting in cells.

Xinrong Liu, Peiyuan Lu, M. Rusckowski, 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Detection of Aspergillus fumigatus pulmonary fungal infections in mice with (99m)Tc-labeled MORF oligomers targeting ribosomal RNA.

Xinrong Liu, Yuzhen Wang, D. Cheng, 2013, Nuclear medicine and biology.

Investigations of a (99m)Tc-labeled bacteriophage as a potential infection-specific imaging agent.

M. Rusckowski, D. Hnatowich, Guozheng Liu, 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Labeling peptides with technetium-99m using a bifunctional chelator of a N-hydroxysuccinimide ester of mercaptoacetyltriglycine.

R. Ladner, A. Ley, M. Rusckowski, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

90Y labeled phosphorodiamidate morpholino oligomer for pretargeting radiotherapy.

Yuzhen Wang, M. Rusckowski, D. Hnatowich, 2011, Bioconjugate chemistry.

Pharmacokinetics of 111In-labeled OC-125 antibody in cancer patients compared with the 19-9 antibody.

D. Shealy, J. Mattis, M. Rusckowski, 1987, Cancer research.

Preparation of (111)In-DTPA morpholino oligomer for low abdominal accumulation.

D. Greiner, M. Rusckowski, D. Hnatowich, 2010, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Directly and indirectly technetium-99m-labeled antibodies--a comparison of in vitro and animal in vivo properties.

P. Winnard, F. Virzi, M. Rusckowski, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Pretargeting using peptide nucleic acid

M. Rusckowski, D. Hnatowich, F. Chang, 1997, Cancer.

Electrostatic binding with tat and other cationic peptides increases cell accumulation of 99mTc-antisense DNAs without entrapment.

M. Rusckowski, D. Hnatowich, Yu-min Zhang, 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

In vitro cell studies of technetium-99m labeled RGD-HYNIC peptide, a comparison of tricine and EDDA as co-ligands.

M. Rusckowski, D. Hnatowich, Jiang He, 2003, Nuclear medicine and biology.

Nitriles form mixed-coligand complexes with (99m)Tc-HYNIC-peptide.

M. Rusckowski, D. Hnatowich, Guozheng Liu, 2002, Nuclear medicine and biology.

A comparison in monkeys of (99m)Tc labeled to a peptide by 4 methods.

S. Gupta, A. Ley, M. Rusckowski, 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Cationic liposomes enhance cellular/nuclear localization of 99mTc-antisense oligonucleotides in target tumor cells.

M. Rusckowski, D. Hnatowich, Y. Zhang, 2001, Cancer biotherapy & radiopharmaceuticals.

Different chelators and different peptides together influence the in vitro and mouse in vivo properties of 99Tcm

M. Rusckowski, T. Qu, Y. Wang, 2001, Nuclear medicine communications.

Technetium-99m antibodies labeled with MAG3 and SHNH: an in vitro and animal in vivo comparison.

M. Rusckowski, G. Mardirossian, K. Lei, 1996, Nuclear medicine and biology.

Can a cysteine challenge assay predict the in vivo behavior of 99mTc-labeled antibodies?

P. Winnard, F. Virzi, M. Rusckowski, 1994, Nuclear medicine and biology.

Initial clinical study of indium-111-labeled clone 110 anticarcinoembryonic antigen antibody in patients with colorectal cancer.

A. Brill, J. Collins, T. Griffin, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pharmacokinetic modeling of radiolabeled antibody distribution in man.

A. Rescigno, A. Brill, T. Griffin, 1990, American journal of physiologic imaging.

Novel DNA Polymer for Amplification Pretargeting.

D. Cheng, Hongcheng Shi, Qingqing Huang, 2015, ACS medicinal chemistry letters.

Ligand-Specific Nano-Contrast Agents Promote Enhanced Breast Cancer CT Detection at 0.5 mg Au

Yuzhen Wang, M. Rusckowski, Kalyan Ramesh, 2022, International journal of molecular sciences.

Further investigations of morpholino pretargeting in mice—establishing quantitative relations in tumor

M. Rusckowski, D. Hnatowich, Guozheng Liu, 2005, European Journal of Nuclear Medicine and Molecular Imaging.

Unexpected side products in the conjugation of an amine-derivatized morpholino oligomer with p-isothiocyanate benzyl DTPA and their removal.

D. Greiner, Minmin Liang, D. Cheng, 2011, Nuclear medicine and biology.

Pharmacokinetics in patients of an anti-carcinoembryonic antigen antibody radiolabeled with indium-111 using a novel diethylenetriamine pentaacetic acid chelator.

A. Rescigno, A. Brill, M. Rusckowski, 1990, Cancer Research.

A new TAG-72 cancer marker peptide identified by phage display.

Xinrong Liu, M. Rusckowski, D. Hnatowich, 2007, Cancer letters.

Imaging of tumor in patients with indium-111-labeled biotin and streptavidin-conjugated antibodies: preliminary communication.

H. Kalofonos, M. Rusckowski, D. Hnatowich, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Comparison between two labeled agents in mice using a coinjection-ratio approach in contrast to a conventional group approach.

B. Barton, D. Greiner, L. Shultz, 2014, Nuclear medicine and biology.

Differentiation between temporary and real non-clearability of biotinylated IgG antibody by avidin in mice

J. Virostko, A. Powers, D. Greiner, 2014, Front. Pharmacol..

(99m)Tc-MORF oligomers specific for bacterial ribosomal RNA as potential specific infection imaging agents.

Xinrong Liu, D. Cheng, M. Rusckowski, 2013, Bioorganic & medicinal chemistry.

In vivo delivery of antisense MORF oligomer by MORF/carrier streptavidin nanoparticles.

Xinrong Liu, M. Rusckowski, D. Hnatowich, 2009, Cancer biotherapy & radiopharmaceuticals.

Successful Radiotherapy of Tumor in Pretargeted Mice by 188Re-Radiolabeled Phosphorodiamidate Morpholino Oligomer, a Synthetic DNA Analogue

Xinrong Liu, M. Rusckowski, D. Hnatowich, 2006, Clinical Cancer Research.

Construction of a novel chimera consisting of a chelator-containing Tat peptide conjugated to a morpholino antisense oligomer for technetium-99m labeling and accelerating cellular kinetics.

C. Tung, J. Vanderheyden, M. Rusckowski, 2006, Nuclear medicine and biology.

Investigations of 99mTc morpholino pretargeting in mice

S. Gupta, G. Liu, M. Rusckowski, 2003, Nuclear medicine communications.

Tumor pretargeting in mice using (99m)Tc-labeled morpholino, a DNA analog.

M. Rusckowski, D. Hnatowich, Guozheng Liu, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Allophycocyanin I and the 95 Kilodalton Polypeptide : The Bridge between Phycobilisomes and Membranes.

B. Zilinskas, M. Rusckowski, 1982, Plant physiology.

Predicting the biodistribution of radiolabeled cMORF effector in MORF-pretargeted mice

Xinrong Liu, M. Rusckowski, D. Hnatowich, 2007, European Journal of Nuclear Medicine and Molecular Imaging.

Effect of endogenous biotin on the applications of streptavidin and biotin in mice.

B. Fritz, M. Rusckowski, D. Hnatowich, 1997, Nuclear medicine and biology.

Adding a clearing agent to pretargeting does not lower the tumor accumulation of the effector as predicted.

Xinrong Liu, M. Rusckowski, D. Hnatowich, 2010, Cancer biotherapy & radiopharmaceuticals.

Radiolabeling of MAG3-morpholino oligomers with 188Re at high labeling efficiency and specific radioactivity for tumor pretargeting.

M. Rusckowski, D. Hnatowich, Guozheng Liu, 2006, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

A Convenient Thiazole Orange Fluorescence Assay for the Evaluation of DNA Duplex Hybridization Stability

Xinrong Liu, Minmin Liang, D. Cheng, 2009, Molecular Imaging and Biology.

Technetium-99m labeled epidermal growth factor-tumor imaging in mice.

M. Rusckowski, F. Chang, T. Qu, 2009, The journal of peptide research : official journal of the American Peptide Society.

A novel and simplified route to the synthesis of N3S chelators for 99mTc labeling.

M. Rusckowski, D. Hnatowich, G. Liu, 2001, Nuclear medicine and biology.

RESEARCH ARTICLE Evaluation of ( 111 In)-Labeled Zinc-Dipicolylamine Tracers for SPECT Imaging of Bacterial Infection

Bradley D. Smith, Yuzhen Wang, M. Rusckowski, 2015 .

Evaluation of [111In]-Labeled Zinc–Dipicolylamine Tracers for SPECT Imaging of Bacterial Infection

Bradley D. Smith, Yuzhen Wang, M. Rusckowski, 2015, Molecular Imaging and Biology.

The ratio of maximum percent tumour accumulations of the pretargeting agent and the radiolabelled effector is independent of tumour size.

Minmin Liang, M. Rusckowski, D. Hnatowich, 2009, European journal of cancer.

Comparing the intracellular fate of components within a noncovalent streptavidin nanoparticle with covalent conjugation.

Xinrong Liu, D. Cheng, M. Rusckowski, 2012, Nuclear medicine and biology.

Initial observations of 99mTc labelled locked nucleic acids for antisense targeting

M. Rusckowski, D. Hnatowich, Guozheng Liu, 2004, Nuclear medicine communications.

Comparing two TAG-72 binding peptides previously identified by phage display as potential imaging agents

Xinrong Liu, D. Cheng, M. Rusckowski, 2011, Nuclear medicine communications.

Identification of a high affinity TAG-72 binding peptide by phage display selection

Xinrong Liu, Minmin Liang, D. Cheng, 2011, Cancer biology & therapy.

Evidence of specificity of radiolabeled phage display peptides for the TAG-72 antigen.

M. Rusckowski, D. Hnatowich, Guozheng Liu, 2007, Cancer biotherapy & radiopharmaceuticals.

In vitro and in vivo evaluation of a Technetium-99m-labeled cyclic RGD peptide as a specific marker of alpha(V)beta(3) integrin for tumor imaging.

Zhihong Zhu, M. Rusckowski, D. Hnatowich, 2002, Bioconjugate chemistry.

Radiolabelling morpholinos with 188Re tricarbonyl provides improved in vitro and in vivo stability to re-oxidation

J. Vanderheyden, M. Rusckowski, D. Hnatowich, 2004, Nuclear medicine communications.

A Keratinocyte-Tethered Biologic Enables Location-Precise Treatment in Mouse Vitiligo.

Yuzhen Wang, J. Richmond, M. Rusckowski, 2022, The Journal of investigative dermatology.

An experimental and theoretical evaluation of the influence of pretargeting antibody on the tumor accumulation of effector

M. Rusckowski, D. Hnatowich, Guozheng Liu, 2008, Molecular Cancer Therapeutics.

Patients Compared with the 19-9 Antibody Pharmacokinetics of 111In-labeled OC-125 Antibody in Cancer

M. Rusckowski, M. Gionet, D. Hnatowich, 2013 .

Evidence of antisense tumor targeting in mice.

S. Gupta, G. Liu, M. Rusckowski, 2004, Bioconjugate chemistry.

Reply to Regarding the mechanism of action of a proposed peptide agonist of the bone morphogenetic protein receptor activin-like kinase 3

V. LeBleu, R. Kalluri, M. Rusckowski, 2013, Nature Network Boston.

Technetium-99m labeled peptides--an investigation of multiple HPLC peaks.

M. Rusckowski, D. Hnatowich, F. Chang, 1999, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Improved tumor localization with (strept)avidin and labeled biotin as a substitute for antibody.

F. Virzi, B. Fritz, M. Rusckowski, 1993, Nuclear medicine and biology.

Localization of infection using streptavidin and biotin: an alternative to nonspecific polyclonal immunoglobulin.

B. Fritz, M. Rusckowski, D. Hnatowich, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A preclinical 188Re tumor therapeutic investigation using MORF/cMORF pretargeting and an antiTAG-72 antibody CC49

S. Baker, D. Cheng, A. Akalin, 2010, Cancer biology & therapy.

NHS-MAS3: a bifunctional chelator alternative to NHS-MAG3.

M. Rusckowski, F. Chang, T. Qu, 1999, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Investigations of avidin and biotin for imaging applications.

F. Virzi, M. Rusckowski, D. Hnatowich, 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Improved Delivery in Cell Culture of Radiolabeled Antisense DNAs by Duplex Formation

Xinrong Liu, M. Rusckowski, D. Hnatowich, 2006, Molecular Imaging and Biology.

Comparison of several linear fluorophore- and quencher-conjugated oligomer duplexes for stability, fluorescence quenching, and kinetics in vitro and in vivo in mice.

Xinrong Liu, M. Rusckowski, D. Hnatowich, 2007, Bioconjugate chemistry.

Biodistribution and metabolism of a mixed backbone oligonucleotide (GEM 231) following single and multiple dose administration in mice.

S. Agrawal, M. Rusckowski, T. Qu, 2000, Antisense & nucleic acid drug development.

Cytosine residues influence kidney accumulations of 99mTc-labeled morpholino oligomers.

M. Rusckowski, D. Hnatowich, Guozheng Liu, 2002, Antisense & nucleic acid drug development.

Chemical modification of mouse interferons.

M. Rusckowski, C. A. Ogburn, B. Dalton, 1982, Journal of interferon research.

In vitro and in vivo assessment of 99mTc-UBI specificity for bacteria.

G. Ferro-Flores, M. Rusckowski, D. Hnatowich, 2003, Nuclear medicine and biology.

Working Out Nephronophthisis Genetics One Family at a Time

A. Roberts, S. Izumo, M. Rusckowski, 2013 .

Influence of different chelators (HYNIC, MAG3 and DTPA) on tumor cell accumulation and mouse biodistribution of technetium-99m labeled to antisense DNA

Ning Liu, Zhihong Zhu, M. Rusckowski, 2000, European Journal of Nuclear Medicine.

The influence of temperature and alkaline pH on the labeling of free and conjugated MAG3 with technetium-99m.

M. Rusckowski, D. Hnatowich, K. Lei, 1997, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Investigations of directly labeling antibodies with rhenium-188.

P. Winnard, M. Rusckowski, D. Hnatowich, 1996, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

Inflammation and infection imaging with a 99mTc-neutrophil elastase inhibitor in monkeys.

R. Ladner, A. Ley, M. Rusckowski, 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Preparation and properties of 99mTc(CO)3+-labeled N,N-bis(2-pyridylmethyl)-4-aminobutyric acid.

J. Vanderheyden, M. Rusckowski, D. Hnatowich, 2004, Bioconjugate chemistry.

Evaluation of technetium Tc 99m-labeled biotin for scintigraphic detection of soft tissue inflammation in horses.

Karen L. Johnson, M. Rusckowski, M. Solano, 2008, American journal of veterinary research.

Imaging osteomyelitis with streptavidin and indium-111-labeled biotin.

F. Fazio, G. Paganelli, F. Virzi, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Influence of endogenous biotin on the biodistribution of labelled biotin derivatives in mice.

F. Virzi, M. Rusckowski, D. Hnatowich, 1995, Nuclear medicine communications.

A novel pretargeting method for measuring antibody internalization in tumor cells.

Xinrong Liu, M. Rusckowski, D. Hnatowich, 2007, Cancer biotherapy & radiopharmaceuticals.

Tumor delivery of antisense oligomer using trastuzumab within a streptavidin nanoparticle

Xinrong Liu, D. Cheng, M. Rusckowski, 2009, European Journal of Nuclear Medicine and Molecular Imaging.

An improved method for covalently conjugating morpholino oligomers to antitumor antibodies.

M. Rusckowski, D. Hnatowich, Guozheng Liu, 2007, Bioconjugate chemistry.

Pretargeting in tumored mice with radiolabeled morpholino oligomer showing low kidney uptake

Jiang He, Guozheng Liu, Jean-Luc Vanderheyden, 2004, European Journal of Nuclear Medicine and Molecular Imaging.

Production and partial purification of rat fibroblast-derived interferon induced in a newly established cell line.

C. T. Davis, M. Rusckowski, D. Goldstein, 1984, Journal of interferon research.

Reducing the background fluorescence in mice receiving fluorophore/inhibitor DNA duplexes.

Xinrong Liu, Minmin Liang, D. Cheng, 2011, Molecular pharmaceutics.

Optical antisense tumor targeting in vivo with an improved fluorescent DNA duplex probe.

Xinrong Liu, Minmin Liang, D. Cheng, 2009, Bioconjugate chemistry.

A simple in vitro method of screening panels of monoclonal antibodies for tumor binding.

P. Doherty, F. Virzi, M. Rusckowski, 1985, Journal of immunological methods.

Production, screening and characterization of a monoclonal antibody to murine interferon-beta.

M. Rusckowski, D. Murasko, 1983, The Journal of general virology.

Imaging Net Retrograde Axonal Transport In Vivo: A Physiological Biomarker

Zuoshang Xu, Wen Xue, Chun‐Qing Song, 2022, Annals of neurology.

In Vitro and in Vivo Evaluation of a Technetium-99m-Labeled Cyclic RGD Peptide as a Specific Marker of αVβ3 Integrin for Tumor Imaging

Zhihong Zhu, M. Rusckowski, D. Hnatowich, 2002 .

In vitro investigations of tumor targeting with (99m)Tc-labeled antisense DNA.

M. Rusckowski, D. Hnatowich, M Rusckowski, 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Pharmacokinetics in mice of four oligomer-conjugated polymers for amplification targeting.

M. Rusckowski, D. Hnatowich, Guozheng Liu, 2003, Cancer biotherapy & radiopharmaceuticals.

A comparison of in vitro and in vivo stability in mice of two morpholino duplexes differing in chain length.

Ning Liu, Jiang He, Surong Zhang, 2003, Bioconjugate chemistry.

Preparation and use of NHS-MAG3 for technetium-99m labeling of DNA.

P. Winnard, M. Rusckowski, D. Hnatowich, 1997, Nuclear medicine and biology.

The influence of chain length and base sequence on the pharmacokinetic behavior of 99mTc-morpholinos in mice.

S. Gupta, G. Liu, M. Rusckowski, 2002, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

Comparative properties of a technetium-99m-labeled single-stranded natural DNA and a phosphorothioate derivative in vitro and in mice.

C. Cantor, C. Smith, P. Winnard, 1996, The Journal of pharmacology and experimental therapeutics.

Recombinant metallothionein-conjugated streptavidin labeled with 188Re and 99mTc.

C. Cantor, C. Smith, P. Winnard, 1995, Bioconjugate chemistry.

Intraperitoneal injection is not always a suitable alternative to intravenous injection for radiotherapy.

Yuzhen Wang, M. Rusckowski, Guozheng Liu, 2013, Cancer biotherapy & radiopharmaceuticals.

Replacing 99mTc with 111In Improves MORF/cMORF Pretargeting by Reducing Intestinal Accumulation

P. Pretorius, Minmin Liang, D. Cheng, 2009, Molecular Imaging and Biology.

Auger Radiation–Induced, Antisense-Mediated Cytotoxicity of Tumor Cells Using a 3-Component Streptavidin-Delivery Nanoparticle with 111In

Xinrong Liu, D. Cheng, A. Akalin, 2009, Journal of Nuclear Medicine.

Multimodality nuclear and fluorescence tumor imaging in mice using a streptavidin nanoparticle.

Yi Wang, Guozheng Liu, Xinrong Liu, 2010, Bioconjugate chemistry.